Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | IKBKB | O14920 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13926047 | 0.84 | IKBKB (0.55) | TP53KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL4127506 | 0.82 | TP53 (0.40) | TP53KDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL4131369 | 0.78 | MAPT (0.60) | TP53MAPT | |
| SCHEMBL4118479 | 0.76 | KDM4E (0.39) | TP53KDM4EMAPTSMN1; SMN2HPGD | |
| SCHEMBL4134050 | 0.75 | TP53 (0.64) | TP53KDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL9542516 | 0.71 | KDM4E (0.40) | KDM4EALDH1A1MAPTSMN1; SMN2RXFP1 | |
| SCHEMBL31758642 | 0.70 | HPGD (0.46) | TP53KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7848765 | 0.70 | MAPT (0.55) | KDM4EALDH1A1MAPTSMN1; SMN2RXFP1 | |
| SCHEMBL7846025 | 0.70 | IKBKB (0.72) | KDM4EALDH1A1MAPTSMN1; SMN2RXFP1 | |
| SCHEMBL4126822 | 0.69 | IKBKB (0.52) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090048286-A1 | Inhibitors of Protein Tyrosine Phosphatase 1B | WYETH (US) | 2009-02-19 | — | — | US | disclosed |
| US-20050203081-A1 | Inhibitors of protein tyrosine phosphatase 1B | WYETH | 2005-09-15 | — | — | US | disclosed |
| WO-2005081960-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B | WYETH (US) | 2005-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203081-A1 | Inhibitors of protein tyrosine phosphatase 1B | PTPRS, PTPRO, PTPRM | TP53 1154/4885KDM4E 899/4885ALDH1A1 2329/4885 |
| US-20090048286-A1 | Inhibitors of Protein Tyrosine Phosphatase 1B | PTPRS, PTPRO, PTPRM | TP53 1154/4885KDM4E 899/4885ALDH1A1 2329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.